nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—ABCC10—Estradiol—osteoporosis	0.289	0.744	CbGbCtD
Gemcitabine—ABCB1—Ethinyl Estradiol—osteoporosis	0.0417	0.108	CbGbCtD
Gemcitabine—ABCB1—Conjugated Estrogens—osteoporosis	0.0306	0.079	CbGbCtD
Gemcitabine—ABCB1—Estradiol—osteoporosis	0.0269	0.0693	CbGbCtD
Gemcitabine—POLD1—uterus—osteoporosis	0.00223	0.0992	CbGeAlD
Gemcitabine—POLE—Fulvestrant—Estradiol—osteoporosis	0.00221	0.226	CbGdCrCtD
Gemcitabine—POLD1—Fulvestrant—Estradiol—osteoporosis	0.00185	0.189	CbGdCrCtD
Gemcitabine—CMPK1—uterus—osteoporosis	0.00178	0.0792	CbGeAlD
Gemcitabine—SLC28A3—bone marrow—osteoporosis	0.00174	0.0772	CbGeAlD
Gemcitabine—CDA—bone marrow—osteoporosis	0.0017	0.0756	CbGeAlD
Gemcitabine—CMPK1—bone marrow—osteoporosis	0.00151	0.0672	CbGeAlD
Gemcitabine—RRM1—Fulvestrant—Estradiol—osteoporosis	0.00147	0.15	CbGdCrCtD
Gemcitabine—POLE—bone marrow—osteoporosis	0.00142	0.063	CbGeAlD
Gemcitabine—RRM2—uterus—osteoporosis	0.00138	0.0611	CbGeAlD
Gemcitabine—POLA1—bone marrow—osteoporosis	0.00122	0.0543	CbGeAlD
Gemcitabine—RRM2—bone marrow—osteoporosis	0.00117	0.0519	CbGeAlD
Gemcitabine—RRM1—uterus—osteoporosis	0.00114	0.0508	CbGeAlD
Gemcitabine—RRM1—bone marrow—osteoporosis	0.00097	0.0431	CbGeAlD
Gemcitabine—SLC29A1—uterus—osteoporosis	0.000929	0.0413	CbGeAlD
Gemcitabine—DCK—uterus—osteoporosis	0.000888	0.0394	CbGeAlD
Gemcitabine—TYMS—bone marrow—osteoporosis	0.000879	0.0391	CbGeAlD
Gemcitabine—ABCC10—uterus—osteoporosis	0.000846	0.0376	CbGeAlD
Gemcitabine—POLD1—Danazol—Ethinyl Estradiol—osteoporosis	0.000808	0.0826	CbGdCrCtD
Gemcitabine—SLC29A1—bone marrow—osteoporosis	0.000789	0.035	CbGeAlD
Gemcitabine—DCK—bone marrow—osteoporosis	0.000753	0.0335	CbGeAlD
Gemcitabine—ABCC10—bone marrow—osteoporosis	0.000718	0.0319	CbGeAlD
Gemcitabine—DCK—Fulvestrant—Estradiol—osteoporosis	0.000523	0.0534	CbGdCrCtD
Gemcitabine—POLA1—Norethindrone—Ethinyl Estradiol—osteoporosis	0.000499	0.051	CbGdCrCtD
Gemcitabine—DCK—Estradiol valerate/Dienogest—Estradiol—osteoporosis	0.00049	0.0501	CbGdCrCtD
Gemcitabine—DCK—Estradiol valerate/Dienogest—Ethinyl Estradiol—osteoporosis	0.000479	0.0489	CbGdCrCtD
Gemcitabine—POLA1—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.000397	0.0406	CbGdCrCtD
Gemcitabine—Oedema—Ethinyl Estradiol—osteoporosis	0.000361	0.000874	CcSEcCtD
Gemcitabine—Erythema—Conjugated Estrogens—osteoporosis	0.000361	0.000873	CcSEcCtD
Gemcitabine—Infection—Ethinyl Estradiol—osteoporosis	0.000359	0.000868	CcSEcCtD
Gemcitabine—Cough—Pamidronate—osteoporosis	0.000358	0.000866	CcSEcCtD
Gemcitabine—Constipation—Calcitriol—osteoporosis	0.000358	0.000866	CcSEcCtD
Gemcitabine—Pain—Calcitriol—osteoporosis	0.000358	0.000866	CcSEcCtD
Gemcitabine—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000354	0.000857	CcSEcCtD
Gemcitabine—Hypertension—Pamidronate—osteoporosis	0.000354	0.000857	CcSEcCtD
Gemcitabine—Diarrhoea—Etidronic acid—osteoporosis	0.000353	0.000853	CcSEcCtD
Gemcitabine—Haematuria—Estradiol—osteoporosis	0.000353	0.000852	CcSEcCtD
Gemcitabine—Body temperature increased—Estropipate—osteoporosis	0.000352	0.000852	CcSEcCtD
Gemcitabine—Feeling abnormal—Ibandronate—osteoporosis	0.000352	0.000852	CcSEcCtD
Gemcitabine—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000351	0.000849	CcSEcCtD
Gemcitabine—Infection—Risedronate—osteoporosis	0.00035	0.000847	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Estradiol—osteoporosis	0.00035	0.000846	CcSEcCtD
Gemcitabine—Myalgia—Pamidronate—osteoporosis	0.000349	0.000845	CcSEcCtD
Gemcitabine—Arthralgia—Pamidronate—osteoporosis	0.000349	0.000845	CcSEcCtD
Gemcitabine—Back pain—Conjugated Estrogens—osteoporosis	0.000349	0.000844	CcSEcCtD
Gemcitabine—Ill-defined disorder—Zoledronate—osteoporosis	0.000348	0.000841	CcSEcCtD
Gemcitabine—Body temperature increased—Alendronate—osteoporosis	0.000347	0.000839	CcSEcCtD
Gemcitabine—Anaemia—Zoledronate—osteoporosis	0.000347	0.000838	CcSEcCtD
Gemcitabine—DCK—Levorphanol—Estradiol—osteoporosis	0.000346	0.0353	CbGdCrCtD
Gemcitabine—Nervous system disorder—Risedronate—osteoporosis	0.000346	0.000836	CcSEcCtD
Gemcitabine—Discomfort—Pamidronate—osteoporosis	0.000345	0.000835	CcSEcCtD
Gemcitabine—Skin disorder—Risedronate—osteoporosis	0.000342	0.000828	CcSEcCtD
Gemcitabine—Body temperature increased—Raloxifene—osteoporosis	0.000341	0.000826	CcSEcCtD
Gemcitabine—Malaise—Zoledronate—osteoporosis	0.000338	0.000818	CcSEcCtD
Gemcitabine—Body temperature increased—Ibandronate—osteoporosis	0.000338	0.000817	CcSEcCtD
Gemcitabine—Leukopenia—Zoledronate—osteoporosis	0.000336	0.000811	CcSEcCtD
Gemcitabine—Oedema—Pamidronate—osteoporosis	0.000335	0.00081	CcSEcCtD
Gemcitabine—Anaphylactic shock—Pamidronate—osteoporosis	0.000335	0.00081	CcSEcCtD
Gemcitabine—Haemoglobin—Estradiol—osteoporosis	0.000334	0.000807	CcSEcCtD
Gemcitabine—Infection—Pamidronate—osteoporosis	0.000333	0.000805	CcSEcCtD
Gemcitabine—Rhinitis—Estradiol—osteoporosis	0.000333	0.000805	CcSEcCtD
Gemcitabine—Haemorrhage—Estradiol—osteoporosis	0.000332	0.000803	CcSEcCtD
Gemcitabine—Body temperature increased—Calcitriol—osteoporosis	0.000331	0.0008	CcSEcCtD
Gemcitabine—Pharyngitis—Estradiol—osteoporosis	0.000329	0.000797	CcSEcCtD
Gemcitabine—Nervous system disorder—Pamidronate—osteoporosis	0.000329	0.000794	CcSEcCtD
Gemcitabine—Thrombocytopenia—Pamidronate—osteoporosis	0.000328	0.000793	CcSEcCtD
Gemcitabine—Urinary tract disorder—Estradiol—osteoporosis	0.000328	0.000793	CcSEcCtD
Gemcitabine—Vomiting—Etidronic acid—osteoporosis	0.000328	0.000792	CcSEcCtD
Gemcitabine—Cough—Zoledronate—osteoporosis	0.000327	0.000791	CcSEcCtD
Gemcitabine—Oedema peripheral—Estradiol—osteoporosis	0.000327	0.000791	CcSEcCtD
Gemcitabine—Connective tissue disorder—Estradiol—osteoporosis	0.000326	0.000789	CcSEcCtD
Gemcitabine—Urethral disorder—Estradiol—osteoporosis	0.000325	0.000787	CcSEcCtD
Gemcitabine—Rash—Etidronic acid—osteoporosis	0.000325	0.000786	CcSEcCtD
Gemcitabine—Dermatitis—Etidronic acid—osteoporosis	0.000325	0.000785	CcSEcCtD
Gemcitabine—Hyperhidrosis—Pamidronate—osteoporosis	0.000324	0.000783	CcSEcCtD
Gemcitabine—Hypertension—Zoledronate—osteoporosis	0.000324	0.000783	CcSEcCtD
Gemcitabine—Headache—Etidronic acid—osteoporosis	0.000323	0.000781	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000321	0.000776	CcSEcCtD
Gemcitabine—Asthenia—Estropipate—osteoporosis	0.00032	0.000774	CcSEcCtD
Gemcitabine—Anorexia—Pamidronate—osteoporosis	0.000319	0.000772	CcSEcCtD
Gemcitabine—Chest pain—Zoledronate—osteoporosis	0.000319	0.000772	CcSEcCtD
Gemcitabine—Arthralgia—Zoledronate—osteoporosis	0.000319	0.000772	CcSEcCtD
Gemcitabine—Myalgia—Zoledronate—osteoporosis	0.000319	0.000772	CcSEcCtD
Gemcitabine—Insomnia—Risedronate—osteoporosis	0.000319	0.000771	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000317	0.000766	CcSEcCtD
Gemcitabine—Paraesthesia—Risedronate—osteoporosis	0.000316	0.000765	CcSEcCtD
Gemcitabine—Pruritus—Estropipate—osteoporosis	0.000315	0.000763	CcSEcCtD
Gemcitabine—Discomfort—Zoledronate—osteoporosis	0.000315	0.000763	CcSEcCtD
Gemcitabine—Asthenia—Alendronate—osteoporosis	0.000315	0.000762	CcSEcCtD
Gemcitabine—Cough—Conjugated Estrogens—osteoporosis	0.000315	0.000762	CcSEcCtD
Gemcitabine—Dyspnoea—Risedronate—osteoporosis	0.000314	0.00076	CcSEcCtD
Gemcitabine—Erythema multiforme—Estradiol—osteoporosis	0.000314	0.000759	CcSEcCtD
Gemcitabine—Hypotension—Pamidronate—osteoporosis	0.000313	0.000757	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000312	0.000755	CcSEcCtD
Gemcitabine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000312	0.000753	CcSEcCtD
Gemcitabine—Pruritus—Alendronate—osteoporosis	0.000311	0.000751	CcSEcCtD
Gemcitabine—Constipation—Ethinyl Estradiol—osteoporosis	0.000309	0.000747	CcSEcCtD
Gemcitabine—Cardiac disorder—Estradiol—osteoporosis	0.000308	0.000745	CcSEcCtD
Gemcitabine—Myalgia—Conjugated Estrogens—osteoporosis	0.000307	0.000743	CcSEcCtD
Gemcitabine—Chest pain—Conjugated Estrogens—osteoporosis	0.000307	0.000743	CcSEcCtD
Gemcitabine—Arthralgia—Conjugated Estrogens—osteoporosis	0.000307	0.000743	CcSEcCtD
Gemcitabine—Asthenia—Ibandronate—osteoporosis	0.000307	0.000742	CcSEcCtD
Gemcitabine—Nausea—Etidronic acid—osteoporosis	0.000306	0.00074	CcSEcCtD
Gemcitabine—Oedema—Zoledronate—osteoporosis	0.000306	0.00074	CcSEcCtD
Gemcitabine—Anaphylactic shock—Zoledronate—osteoporosis	0.000306	0.00074	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000305	0.000738	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000305	0.000738	CcSEcCtD
Gemcitabine—Diarrhoea—Estropipate—osteoporosis	0.000305	0.000738	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000304	0.000736	CcSEcCtD
Gemcitabine—Infection—Zoledronate—osteoporosis	0.000304	0.000735	CcSEcCtD
Gemcitabine—Fatigue—Risedronate—osteoporosis	0.000304	0.000735	CcSEcCtD
Gemcitabine—Insomnia—Pamidronate—osteoporosis	0.000303	0.000733	CcSEcCtD
Gemcitabine—Pruritus—Ibandronate—osteoporosis	0.000303	0.000732	CcSEcCtD
Gemcitabine—Pain—Risedronate—osteoporosis	0.000301	0.000729	CcSEcCtD
Gemcitabine—Constipation—Risedronate—osteoporosis	0.000301	0.000729	CcSEcCtD
Gemcitabine—Angiopathy—Estradiol—osteoporosis	0.000301	0.000728	CcSEcCtD
Gemcitabine—Paraesthesia—Pamidronate—osteoporosis	0.000301	0.000727	CcSEcCtD
Gemcitabine—Diarrhoea—Alendronate—osteoporosis	0.0003	0.000727	CcSEcCtD
Gemcitabine—Asthenia—Calcitriol—osteoporosis	0.0003	0.000726	CcSEcCtD
Gemcitabine—Nervous system disorder—Zoledronate—osteoporosis	0.0003	0.000726	CcSEcCtD
Gemcitabine—Immune system disorder—Estradiol—osteoporosis	0.0003	0.000725	CcSEcCtD
Gemcitabine—Thrombocytopenia—Zoledronate—osteoporosis	0.0003	0.000724	CcSEcCtD
Gemcitabine—Mediastinal disorder—Estradiol—osteoporosis	0.000299	0.000723	CcSEcCtD
Gemcitabine—Dyspnoea—Pamidronate—osteoporosis	0.000299	0.000722	CcSEcCtD
Gemcitabine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000298	0.00072	CcSEcCtD
Gemcitabine—Chills—Estradiol—osteoporosis	0.000298	0.00072	CcSEcCtD
Gemcitabine—Somnolence—Pamidronate—osteoporosis	0.000298	0.00072	CcSEcCtD
Gemcitabine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000298	0.00179	CbGpPWpGaD
Gemcitabine—Skin disorder—Zoledronate—osteoporosis	0.000297	0.000719	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000297	0.00179	CbGpPWpGaD
Gemcitabine—Pruritus—Calcitriol—osteoporosis	0.000296	0.000716	CcSEcCtD
Gemcitabine—Hyperhidrosis—Zoledronate—osteoporosis	0.000296	0.000715	CcSEcCtD
Gemcitabine—Diarrhoea—Raloxifene—osteoporosis	0.000296	0.000715	CcSEcCtD
Gemcitabine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000295	0.000712	CcSEcCtD
Gemcitabine—Oedema—Conjugated Estrogens—osteoporosis	0.000295	0.000712	CcSEcCtD
Gemcitabine—Alopecia—Estradiol—osteoporosis	0.000293	0.000709	CcSEcCtD
Gemcitabine—Infection—Conjugated Estrogens—osteoporosis	0.000293	0.000708	CcSEcCtD
Gemcitabine—Diarrhoea—Ibandronate—osteoporosis	0.000293	0.000707	CcSEcCtD
Gemcitabine—Anorexia—Zoledronate—osteoporosis	0.000292	0.000705	CcSEcCtD
Gemcitabine—Decreased appetite—Pamidronate—osteoporosis	0.000291	0.000704	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000289	0.000699	CcSEcCtD
Gemcitabine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000289	0.000699	CcSEcCtD
Gemcitabine—Erythema—Estradiol—osteoporosis	0.000289	0.000699	CcSEcCtD
Gemcitabine—Fatigue—Pamidronate—osteoporosis	0.000289	0.000698	CcSEcCtD
Gemcitabine—Pain—Pamidronate—osteoporosis	0.000286	0.000693	CcSEcCtD
Gemcitabine—Constipation—Pamidronate—osteoporosis	0.000286	0.000693	CcSEcCtD
Gemcitabine—Diarrhoea—Calcitriol—osteoporosis	0.000286	0.000693	CcSEcCtD
Gemcitabine—Skin disorder—Conjugated Estrogens—osteoporosis	0.000286	0.000692	CcSEcCtD
Gemcitabine—Hypotension—Zoledronate—osteoporosis	0.000286	0.000691	CcSEcCtD
Gemcitabine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000286	0.000691	CcSEcCtD
Gemcitabine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000285	0.000689	CcSEcCtD
Gemcitabine—Vomiting—Estropipate—osteoporosis	0.000284	0.000686	CcSEcCtD
Gemcitabine—Rash—Estropipate—osteoporosis	0.000281	0.00068	CcSEcCtD
Gemcitabine—Dermatitis—Estropipate—osteoporosis	0.000281	0.000679	CcSEcCtD
Gemcitabine—Anorexia—Conjugated Estrogens—osteoporosis	0.000281	0.000679	CcSEcCtD
Gemcitabine—Back pain—Estradiol—osteoporosis	0.000279	0.000676	CcSEcCtD
Gemcitabine—Headache—Estropipate—osteoporosis	0.000279	0.000675	CcSEcCtD
Gemcitabine—Vomiting—Alendronate—osteoporosis	0.000279	0.000675	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000279	0.000674	CcSEcCtD
Gemcitabine—Body temperature increased—Risedronate—osteoporosis	0.000279	0.000674	CcSEcCtD
Gemcitabine—Rash—Alendronate—osteoporosis	0.000277	0.00067	CcSEcCtD
Gemcitabine—Insomnia—Zoledronate—osteoporosis	0.000277	0.000669	CcSEcCtD
Gemcitabine—Dermatitis—Alendronate—osteoporosis	0.000277	0.000669	CcSEcCtD
Gemcitabine—Feeling abnormal—Pamidronate—osteoporosis	0.000276	0.000667	CcSEcCtD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	0.000276	0.00166	CbGpPWpGaD
Gemcitabine—Hypotension—Conjugated Estrogens—osteoporosis	0.000275	0.000666	CcSEcCtD
Gemcitabine—Headache—Alendronate—osteoporosis	0.000275	0.000665	CcSEcCtD
Gemcitabine—Paraesthesia—Zoledronate—osteoporosis	0.000275	0.000664	CcSEcCtD
Gemcitabine—RRM1—Metabolism—ATIC—osteoporosis	0.000275	0.00165	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PNP—osteoporosis	0.000275	0.00165	CbGpPWpGaD
Gemcitabine—Vomiting—Raloxifene—osteoporosis	0.000275	0.000664	CcSEcCtD
Gemcitabine—Dyspnoea—Zoledronate—osteoporosis	0.000273	0.00066	CcSEcCtD
Gemcitabine—Rash—Raloxifene—osteoporosis	0.000272	0.000659	CcSEcCtD
Gemcitabine—Dermatitis—Raloxifene—osteoporosis	0.000272	0.000658	CcSEcCtD
Gemcitabine—Somnolence—Zoledronate—osteoporosis	0.000272	0.000658	CcSEcCtD
Gemcitabine—Vomiting—Ibandronate—osteoporosis	0.000272	0.000657	CcSEcCtD
Gemcitabine—Headache—Raloxifene—osteoporosis	0.000271	0.000654	CcSEcCtD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.00027	0.00162	CbGpPWpGaD
Gemcitabine—Rash—Ibandronate—osteoporosis	0.00027	0.000652	CcSEcCtD
Gemcitabine—Dermatitis—Ibandronate—osteoporosis	0.000269	0.000651	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000268	0.000649	CcSEcCtD
Gemcitabine—Ill-defined disorder—Estradiol—osteoporosis	0.000268	0.000648	CcSEcCtD
Gemcitabine—Headache—Ibandronate—osteoporosis	0.000268	0.000648	CcSEcCtD
Gemcitabine—Insomnia—Conjugated Estrogens—osteoporosis	0.000266	0.000644	CcSEcCtD
Gemcitabine—Vomiting—Calcitriol—osteoporosis	0.000266	0.000644	CcSEcCtD
Gemcitabine—Decreased appetite—Zoledronate—osteoporosis	0.000266	0.000643	CcSEcCtD
Gemcitabine—Nausea—Estropipate—osteoporosis	0.000265	0.00064	CcSEcCtD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	0.000265	0.00159	CbGpPWpGaD
Gemcitabine—Body temperature increased—Pamidronate—osteoporosis	0.000265	0.00064	CcSEcCtD
Gemcitabine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000265	0.00064	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000264	0.000639	CcSEcCtD
Gemcitabine—Rash—Calcitriol—osteoporosis	0.000264	0.000638	CcSEcCtD
Gemcitabine—Fatigue—Zoledronate—osteoporosis	0.000264	0.000638	CcSEcCtD
Gemcitabine—Dermatitis—Calcitriol—osteoporosis	0.000264	0.000638	CcSEcCtD
Gemcitabine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000263	0.000635	CcSEcCtD
Gemcitabine—Headache—Calcitriol—osteoporosis	0.000262	0.000634	CcSEcCtD
Gemcitabine—Somnolence—Conjugated Estrogens—osteoporosis	0.000262	0.000633	CcSEcCtD
Gemcitabine—Pain—Zoledronate—osteoporosis	0.000262	0.000633	CcSEcCtD
Gemcitabine—Constipation—Zoledronate—osteoporosis	0.000262	0.000633	CcSEcCtD
Gemcitabine—RRM2—Metabolism—PKM—osteoporosis	0.000261	0.00157	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—FDPS—osteoporosis	0.000261	0.00157	CbGpPWpGaD
Gemcitabine—Nausea—Alendronate—osteoporosis	0.000261	0.000631	CcSEcCtD
Gemcitabine—Malaise—Estradiol—osteoporosis	0.000261	0.00063	CcSEcCtD
Gemcitabine—TYMS—Levorphanol—Estradiol—osteoporosis	0.00026	0.0266	CbGdCrCtD
Gemcitabine—POLD1—Metabolism—PKM—osteoporosis	0.000259	0.00156	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—FDPS—osteoporosis	0.000259	0.00156	CbGpPWpGaD
Gemcitabine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000259	0.000627	CcSEcCtD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	0.000258	0.00155	CbGpPWpGaD
Gemcitabine—Nausea—Raloxifene—osteoporosis	0.000257	0.00062	CcSEcCtD
Gemcitabine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000256	0.000619	CcSEcCtD
Gemcitabine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000256	0.000618	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—ENO1—osteoporosis	0.000255	0.00154	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—IDH2—osteoporosis	0.000255	0.00154	CbGpPWpGaD
Gemcitabine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000254	0.000615	CcSEcCtD
Gemcitabine—Fatigue—Conjugated Estrogens—osteoporosis	0.000254	0.000614	CcSEcCtD
Gemcitabine—Nausea—Ibandronate—osteoporosis	0.000254	0.000614	CcSEcCtD
Gemcitabine—Asthenia—Risedronate—osteoporosis	0.000253	0.000611	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.000253	0.00152	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.000253	0.00152	CbGpPWpGaD
Gemcitabine—Feeling abnormal—Zoledronate—osteoporosis	0.000252	0.00061	CcSEcCtD
Gemcitabine—Cough—Estradiol—osteoporosis	0.000252	0.00061	CcSEcCtD
Gemcitabine—Pain—Conjugated Estrogens—osteoporosis	0.000252	0.000609	CcSEcCtD
Gemcitabine—Constipation—Conjugated Estrogens—osteoporosis	0.000252	0.000609	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—PSMA2—osteoporosis	0.000252	0.00151	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PSMA5—osteoporosis	0.000252	0.00151	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.000251	0.00151	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.000251	0.00151	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—ENO1—osteoporosis	0.000251	0.00151	CbGpPWpGaD
Gemcitabine—Hypertension—Estradiol—osteoporosis	0.000249	0.000603	CcSEcCtD
Gemcitabine—Pruritus—Risedronate—osteoporosis	0.000249	0.000603	CcSEcCtD
Gemcitabine—Nausea—Calcitriol—osteoporosis	0.000249	0.000601	CcSEcCtD
Gemcitabine—RRM2—Metabolism—GPD2—osteoporosis	0.000247	0.00149	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PGLS—osteoporosis	0.000247	0.00149	CbGpPWpGaD
Gemcitabine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000247	0.000598	CcSEcCtD
Gemcitabine—Arthralgia—Estradiol—osteoporosis	0.000246	0.000595	CcSEcCtD
Gemcitabine—Chest pain—Estradiol—osteoporosis	0.000246	0.000595	CcSEcCtD
Gemcitabine—Myalgia—Estradiol—osteoporosis	0.000246	0.000595	CcSEcCtD
Gemcitabine—POLD1—Metabolism—GPD2—osteoporosis	0.000246	0.00148	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PGLS—osteoporosis	0.000246	0.00148	CbGpPWpGaD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000244	0.000591	CcSEcCtD
Gemcitabine—ABCB1—uterus—osteoporosis	0.000244	0.0108	CbGeAlD
Gemcitabine—DCK—Metabolism—PKM—osteoporosis	0.000244	0.00147	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—FDPS—osteoporosis	0.000244	0.00147	CbGpPWpGaD
Gemcitabine—Discomfort—Estradiol—osteoporosis	0.000243	0.000588	CcSEcCtD
Gemcitabine—POLE—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.000242	0.00146	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.000242	0.00146	CbGpPWpGaD
Gemcitabine—Body temperature increased—Zoledronate—osteoporosis	0.000242	0.000585	CcSEcCtD
Gemcitabine—Diarrhoea—Risedronate—osteoporosis	0.000241	0.000583	CcSEcCtD
Gemcitabine—Asthenia—Pamidronate—osteoporosis	0.00024	0.000581	CcSEcCtD
Gemcitabine—CDA—Metabolism—CYP27A1—osteoporosis	0.00024	0.00144	CbGpPWpGaD
Gemcitabine—Pruritus—Pamidronate—osteoporosis	0.000237	0.000573	CcSEcCtD
Gemcitabine—Anaphylactic shock—Estradiol—osteoporosis	0.000236	0.00057	CcSEcCtD
Gemcitabine—Oedema—Estradiol—osteoporosis	0.000236	0.00057	CcSEcCtD
Gemcitabine—Infection—Estradiol—osteoporosis	0.000234	0.000566	CcSEcCtD
Gemcitabine—RRM1—Metabolism—OXCT1—osteoporosis	0.000234	0.00141	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CA2—osteoporosis	0.000234	0.00141	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—ACP5—osteoporosis	0.000234	0.00141	CbGpPWpGaD
Gemcitabine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000233	0.000563	CcSEcCtD
Gemcitabine—Nervous system disorder—Estradiol—osteoporosis	0.000231	0.000559	CcSEcCtD
Gemcitabine—DCK—Metabolism—GPD2—osteoporosis	0.000231	0.00139	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PGLS—osteoporosis	0.000231	0.00139	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic M-M/G1 phases—PSMA2—osteoporosis	0.000231	0.00139	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic M-M/G1 phases—PSMA5—osteoporosis	0.000231	0.00139	CbGpPWpGaD
Gemcitabine—RRM2—G1/S Transition—MYC—osteoporosis	0.00023	0.00139	CbGpPWpGaD
Gemcitabine—Vomiting—Ethinyl Estradiol—osteoporosis	0.00023	0.000556	CcSEcCtD
Gemcitabine—Diarrhoea—Pamidronate—osteoporosis	0.000229	0.000554	CcSEcCtD
Gemcitabine—Skin disorder—Estradiol—osteoporosis	0.000229	0.000554	CcSEcCtD
Gemcitabine—Hyperhidrosis—Estradiol—osteoporosis	0.000228	0.000551	CcSEcCtD
Gemcitabine—Rash—Ethinyl Estradiol—osteoporosis	0.000228	0.000551	CcSEcCtD
Gemcitabine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000228	0.000551	CcSEcCtD
Gemcitabine—RRM1—Metabolism—MGLL—osteoporosis	0.000228	0.00137	CbGpPWpGaD
Gemcitabine—Headache—Ethinyl Estradiol—osteoporosis	0.000226	0.000547	CcSEcCtD
Gemcitabine—RRM2—Metabolism—ATIC—osteoporosis	0.000226	0.00136	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PNP—osteoporosis	0.000226	0.00136	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—PSMA2—osteoporosis	0.000226	0.00136	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—PSMA5—osteoporosis	0.000226	0.00136	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ATIC—osteoporosis	0.000225	0.00135	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PNP—osteoporosis	0.000225	0.00135	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—PSMA5—osteoporosis	0.000224	0.00135	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—PSMA2—osteoporosis	0.000224	0.00135	CbGpPWpGaD
Gemcitabine—Vomiting—Risedronate—osteoporosis	0.000224	0.000542	CcSEcCtD
Gemcitabine—Rash—Risedronate—osteoporosis	0.000222	0.000537	CcSEcCtD
Gemcitabine—Dermatitis—Risedronate—osteoporosis	0.000222	0.000537	CcSEcCtD
Gemcitabine—POLE—G1/S Transition—MYC—osteoporosis	0.000221	0.00133	CbGpPWpGaD
Gemcitabine—Headache—Risedronate—osteoporosis	0.000221	0.000534	CcSEcCtD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.00022	0.00132	CbGpPWpGaD
Gemcitabine—Asthenia—Zoledronate—osteoporosis	0.00022	0.000531	CcSEcCtD
Gemcitabine—CDA—Metabolism—TPI1—osteoporosis	0.000217	0.00131	CbGpPWpGaD
Gemcitabine—POLA1—E2F transcription factor network—MYC—osteoporosis	0.000217	0.00131	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—PSMA2—osteoporosis	0.000217	0.0013	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—PSMA5—osteoporosis	0.000217	0.0013	CbGpPWpGaD
Gemcitabine—Pruritus—Zoledronate—osteoporosis	0.000216	0.000523	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000215	0.000519	CcSEcCtD
Gemcitabine—Nausea—Ethinyl Estradiol—osteoporosis	0.000215	0.000519	CcSEcCtD
Gemcitabine—Insomnia—Estradiol—osteoporosis	0.000213	0.000516	CcSEcCtD
Gemcitabine—Vomiting—Pamidronate—osteoporosis	0.000213	0.000515	CcSEcCtD
Gemcitabine—Paraesthesia—Estradiol—osteoporosis	0.000212	0.000512	CcSEcCtD
Gemcitabine—DCK—Metabolism—ATIC—osteoporosis	0.000211	0.00127	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PNP—osteoporosis	0.000211	0.00127	CbGpPWpGaD
Gemcitabine—Asthenia—Conjugated Estrogens—osteoporosis	0.000211	0.000511	CcSEcCtD
Gemcitabine—Rash—Pamidronate—osteoporosis	0.000211	0.000511	CcSEcCtD
Gemcitabine—Dermatitis—Pamidronate—osteoporosis	0.000211	0.00051	CcSEcCtD
Gemcitabine—Dyspnoea—Estradiol—osteoporosis	0.00021	0.000508	CcSEcCtD
Gemcitabine—Headache—Pamidronate—osteoporosis	0.00021	0.000507	CcSEcCtD
Gemcitabine—Somnolence—Estradiol—osteoporosis	0.00021	0.000507	CcSEcCtD
Gemcitabine—Diarrhoea—Zoledronate—osteoporosis	0.000209	0.000506	CcSEcCtD
Gemcitabine—Nausea—Risedronate—osteoporosis	0.000209	0.000506	CcSEcCtD
Gemcitabine—Pruritus—Conjugated Estrogens—osteoporosis	0.000208	0.000504	CcSEcCtD
Gemcitabine—TYMS—E2F transcription factor network—MYC—osteoporosis	0.000208	0.00125	CbGpPWpGaD
Gemcitabine—POLD1—S Phase—MYC—osteoporosis	0.000208	0.00125	CbGpPWpGaD
Gemcitabine—ABCB1—bone marrow—osteoporosis	0.000207	0.0092	CbGeAlD
Gemcitabine—Decreased appetite—Estradiol—osteoporosis	0.000205	0.000496	CcSEcCtD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000205	0.00123	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—CYP19A1—osteoporosis	0.000204	0.00123	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—P4HB—osteoporosis	0.000204	0.00123	CbGpPWpGaD
Gemcitabine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000204	0.000492	CcSEcCtD
Gemcitabine—Fatigue—Estradiol—osteoporosis	0.000203	0.000492	CcSEcCtD
Gemcitabine—Pain—Estradiol—osteoporosis	0.000202	0.000488	CcSEcCtD
Gemcitabine—Constipation—Estradiol—osteoporosis	0.000202	0.000488	CcSEcCtD
Gemcitabine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000202	0.000487	CcSEcCtD
Gemcitabine—POLE—S Phase—MYC—osteoporosis	0.000201	0.00121	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—GAPDH—osteoporosis	0.0002	0.00121	CbGpPWpGaD
Gemcitabine—Nausea—Pamidronate—osteoporosis	0.000199	0.000481	CcSEcCtD
Gemcitabine—CDA—Metabolism—RAP1A—osteoporosis	0.000195	0.00117	CbGpPWpGaD
Gemcitabine—Vomiting—Zoledronate—osteoporosis	0.000195	0.00047	CcSEcCtD
Gemcitabine—Feeling abnormal—Estradiol—osteoporosis	0.000194	0.00047	CcSEcCtD
Gemcitabine—RRM2—Mitotic G1-G1/S phases—MYC—osteoporosis	0.000194	0.00117	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—IDH2—osteoporosis	0.000194	0.00116	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.000193	0.00116	CbGpPWpGaD
Gemcitabine—Rash—Zoledronate—osteoporosis	0.000193	0.000467	CcSEcCtD
Gemcitabine—Dermatitis—Zoledronate—osteoporosis	0.000193	0.000466	CcSEcCtD
Gemcitabine—RRM2—Metabolism—CA2—osteoporosis	0.000192	0.00116	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—OXCT1—osteoporosis	0.000192	0.00116	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000192	0.00116	CbGpPWpGaD
Gemcitabine—Headache—Zoledronate—osteoporosis	0.000192	0.000464	CcSEcCtD
Gemcitabine—POLD1—Metabolism—OXCT1—osteoporosis	0.000191	0.00115	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CA2—osteoporosis	0.000191	0.00115	CbGpPWpGaD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	0.000189	0.00114	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—MGLL—osteoporosis	0.000187	0.00113	CbGpPWpGaD
Gemcitabine—Vomiting—Conjugated Estrogens—osteoporosis	0.000187	0.000453	CcSEcCtD
Gemcitabine—Body temperature increased—Estradiol—osteoporosis	0.000186	0.000451	CcSEcCtD
Gemcitabine—POLE—Mitotic G1-G1/S phases—MYC—osteoporosis	0.000186	0.00112	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—MGLL—osteoporosis	0.000186	0.00112	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—LEP—osteoporosis	0.000186	0.00112	CbGpPWpGaD
Gemcitabine—Rash—Conjugated Estrogens—osteoporosis	0.000186	0.000449	CcSEcCtD
Gemcitabine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000186	0.000449	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.000185	0.00111	CbGpPWpGaD
Gemcitabine—Headache—Conjugated Estrogens—osteoporosis	0.000185	0.000446	CcSEcCtD
Gemcitabine—RRM1—Metabolism—CYP27A1—osteoporosis	0.000182	0.00109	CbGpPWpGaD
Gemcitabine—Nausea—Zoledronate—osteoporosis	0.000182	0.000439	CcSEcCtD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	0.000181	0.00109	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CA2—osteoporosis	0.00018	0.00108	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—OXCT1—osteoporosis	0.00018	0.00108	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.000179	0.00107	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.000178	0.00107	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—ACP5—osteoporosis	0.000177	0.00106	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—MGLL—osteoporosis	0.000175	0.00105	CbGpPWpGaD
Gemcitabine—Nausea—Conjugated Estrogens—osteoporosis	0.000175	0.000423	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.000173	0.00104	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.000173	0.00104	CbGpPWpGaD
Gemcitabine—TYMS—Danazol—Ethinyl Estradiol—osteoporosis	0.000172	0.0176	CbGdCrCtD
Gemcitabine—TYMS—Metabolism—PKM—osteoporosis	0.000171	0.00103	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—FDPS—osteoporosis	0.000171	0.00103	CbGpPWpGaD
Gemcitabine—Asthenia—Estradiol—osteoporosis	0.000169	0.000409	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000167	0.00101	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—ADCY5—osteoporosis	0.000167	0.001	CbGpPWpGaD
Gemcitabine—Pruritus—Estradiol—osteoporosis	0.000167	0.000403	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	0.000166	0.001	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—GPX1—osteoporosis	0.000166	0.001	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.000166	0.000996	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.000166	0.000996	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—TPI1—osteoporosis	0.000165	0.00099	CbGpPWpGaD
Gemcitabine—DCK—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.000164	0.0167	CbGdCrCtD
Gemcitabine—TYMS—Metabolism—PGLS—osteoporosis	0.000162	0.000975	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GPD2—osteoporosis	0.000162	0.000975	CbGpPWpGaD
Gemcitabine—Diarrhoea—Estradiol—osteoporosis	0.000161	0.00039	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.00016	0.000965	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—IDH2—osteoporosis	0.000159	0.000959	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—IDH2—osteoporosis	0.000158	0.000953	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—ENO1—osteoporosis	0.000158	0.000949	CbGpPWpGaD
Gemcitabine—POLA1—G1/S Transition—MYC—osteoporosis	0.000158	0.000948	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PSMA2—osteoporosis	0.000155	0.000935	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PSMA5—osteoporosis	0.000155	0.000935	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—P4HB—osteoporosis	0.000155	0.000931	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—PSMA2—osteoporosis	0.000154	0.000929	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—PSMA5—osteoporosis	0.000154	0.000929	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—MTHFR—osteoporosis	0.000153	0.000923	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000153	0.000917	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GAPDH—osteoporosis	0.000152	0.000914	CbGpPWpGaD
Gemcitabine—TYMS—G1/S Transition—MYC—osteoporosis	0.000151	0.000908	CbGpPWpGaD
Gemcitabine—Vomiting—Estradiol—osteoporosis	0.00015	0.000363	CcSEcCtD
Gemcitabine—RRM2—Metabolism—CYP27A1—osteoporosis	0.00015	0.000901	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CYP27A1—osteoporosis	0.000149	0.000896	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—IDH2—osteoporosis	0.000149	0.000896	CbGpPWpGaD
Gemcitabine—Rash—Estradiol—osteoporosis	0.000149	0.00036	CcSEcCtD
Gemcitabine—Dermatitis—Estradiol—osteoporosis	0.000149	0.000359	CcSEcCtD
Gemcitabine—TYMS—Metabolism—PNP—osteoporosis	0.000148	0.000892	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ATIC—osteoporosis	0.000148	0.000892	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—PSMA2—osteoporosis	0.000148	0.00089	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—PSMA5—osteoporosis	0.000148	0.00089	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—RAP1A—osteoporosis	0.000148	0.00089	CbGpPWpGaD
Gemcitabine—Headache—Estradiol—osteoporosis	0.000148	0.000357	CcSEcCtD
Gemcitabine—RRM2—Metabolism—ACP5—osteoporosis	0.000146	0.000877	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ACP5—osteoporosis	0.000145	0.000872	CbGpPWpGaD
Gemcitabine—POLA1—S Phase—MYC—osteoporosis	0.000143	0.00086	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	0.00014	0.000843	CbGpPWpGaD
Gemcitabine—Nausea—Estradiol—osteoporosis	0.00014	0.000339	CcSEcCtD
Gemcitabine—DCK—Metabolism—CYP27A1—osteoporosis	0.00014	0.000842	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ACP5—osteoporosis	0.000136	0.000819	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—TPI1—osteoporosis	0.000136	0.000815	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—TPI1—osteoporosis	0.000135	0.00081	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—MYC—osteoporosis	0.000133	0.000799	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.000132	0.000797	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—P4HB—osteoporosis	0.000127	0.000766	CbGpPWpGaD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—MYC—osteoporosis	0.000127	0.000765	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—P4HB—osteoporosis	0.000127	0.000762	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—TPI1—osteoporosis	0.000127	0.000762	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—CYP19A1—osteoporosis	0.000126	0.000759	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CA2—osteoporosis	0.000126	0.000758	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—OXCT1—osteoporosis	0.000126	0.000758	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GAPDH—osteoporosis	0.000125	0.000752	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GAPDH—osteoporosis	0.000124	0.000748	CbGpPWpGaD
Gemcitabine—TYMS—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.000123	0.0126	CbGdCrCtD
Gemcitabine—TYMS—Metabolism—MGLL—osteoporosis	0.000123	0.000739	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—POMC—osteoporosis	0.000123	0.000738	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—RAP1A—osteoporosis	0.000122	0.000733	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—RAP1A—osteoporosis	0.000121	0.000728	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—ENO1—osteoporosis	0.00012	0.000719	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—P4HB—osteoporosis	0.000119	0.000716	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PSMA2—osteoporosis	0.000118	0.000709	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PSMA5—osteoporosis	0.000118	0.000709	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GAPDH—osteoporosis	0.000117	0.000703	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—RAP1A—osteoporosis	0.000114	0.000685	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—IDH2—osteoporosis	0.000104	0.000628	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—ADCY5—osteoporosis	0.000103	0.00062	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—GPX1—osteoporosis	0.000103	0.000618	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.000101	0.000605	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.0001	0.000604	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ENO1—osteoporosis	9.85e-05	0.000592	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP27A1—osteoporosis	9.82e-05	0.000591	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ENO1—osteoporosis	9.79e-05	0.000589	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PSMA5—osteoporosis	9.7e-05	0.000584	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PSMA2—osteoporosis	9.7e-05	0.000584	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PSMA5—osteoporosis	9.64e-05	0.00058	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PSMA2—osteoporosis	9.64e-05	0.00058	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	9.64e-05	0.00058	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	9.61e-05	0.000578	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CYP19A1—osteoporosis	9.56e-05	0.000575	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ACP5—osteoporosis	9.55e-05	0.000575	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—MTHFR—osteoporosis	9.48e-05	0.00057	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	9.43e-05	0.000567	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	9.37e-05	0.000564	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ENO1—osteoporosis	9.2e-05	0.000554	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PSMA2—osteoporosis	9.07e-05	0.000545	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PSMA5—osteoporosis	9.07e-05	0.000545	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	8.98e-05	0.00054	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—TPI1—osteoporosis	8.88e-05	0.000534	CbGpPWpGaD
Gemcitabine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	8.83e-05	0.000531	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—P4HB—osteoporosis	8.35e-05	0.000502	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GAPDH—osteoporosis	8.2e-05	0.000493	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—RAP1A—osteoporosis	7.98e-05	0.00048	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CYP19A1—osteoporosis	7.87e-05	0.000474	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CYP19A1—osteoporosis	7.82e-05	0.000471	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—ADCY5—osteoporosis	7.81e-05	0.00047	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GPX1—osteoporosis	7.78e-05	0.000468	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL1B—osteoporosis	7.74e-05	0.000465	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—POMC—osteoporosis	7.58e-05	0.000456	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	7.4e-05	0.000445	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CYP19A1—osteoporosis	7.36e-05	0.000443	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—MTHFR—osteoporosis	7.18e-05	0.000432	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—MYC—osteoporosis	7.12e-05	0.000428	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—MYC—osteoporosis	7.08e-05	0.000426	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—IL6—osteoporosis	6.95e-05	0.000418	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—MYC—osteoporosis	6.83e-05	0.000411	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ENO1—osteoporosis	6.45e-05	0.000388	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ADCY5—osteoporosis	6.43e-05	0.000387	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GPX1—osteoporosis	6.41e-05	0.000386	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ADCY5—osteoporosis	6.39e-05	0.000385	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GPX1—osteoporosis	6.37e-05	0.000383	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—MYC—osteoporosis	6.37e-05	0.000383	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PSMA2—osteoporosis	6.36e-05	0.000382	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PSMA5—osteoporosis	6.36e-05	0.000382	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—MYC—osteoporosis	6.33e-05	0.000381	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—MYC—osteoporosis	6.11e-05	0.000368	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—TGFB1—osteoporosis	6.01e-05	0.000362	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ADCY5—osteoporosis	6.01e-05	0.000362	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GPX1—osteoporosis	5.99e-05	0.00036	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—MTHFR—osteoporosis	5.92e-05	0.000356	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—MTHFR—osteoporosis	5.88e-05	0.000354	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—POMC—osteoporosis	5.75e-05	0.000346	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	5.72e-05	0.000344	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—TNF—osteoporosis	5.61e-05	0.000338	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—MTHFR—osteoporosis	5.53e-05	0.000333	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—FDPS—osteoporosis	5.28e-05	0.000317	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PKM—osteoporosis	5.28e-05	0.000317	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP19A1—osteoporosis	5.16e-05	0.00031	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PGLS—osteoporosis	5e-05	0.000301	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GPD2—osteoporosis	5e-05	0.000301	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	4.95e-05	0.000298	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—MYC—osteoporosis	4.87e-05	0.000293	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—POMC—osteoporosis	4.73e-05	0.000285	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—POMC—osteoporosis	4.7e-05	0.000283	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—MYC—osteoporosis	4.67e-05	0.000281	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ATIC—osteoporosis	4.57e-05	0.000275	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PNP—osteoporosis	4.57e-05	0.000275	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—POMC—osteoporosis	4.42e-05	0.000266	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MYC—osteoporosis	4.35e-05	0.000262	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ADCY5—osteoporosis	4.22e-05	0.000254	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GPX1—osteoporosis	4.2e-05	0.000253	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MYC—osteoporosis	4.17e-05	0.000251	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CA2—osteoporosis	3.89e-05	0.000234	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—OXCT1—osteoporosis	3.89e-05	0.000234	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—MTHFR—osteoporosis	3.88e-05	0.000233	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—MGLL—osteoporosis	3.79e-05	0.000228	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—IDH2—osteoporosis	3.22e-05	0.000194	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—POMC—osteoporosis	3.1e-05	0.000186	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP27A1—osteoporosis	3.03e-05	0.000182	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	2.97e-05	0.000179	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	2.97e-05	0.000178	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ACP5—osteoporosis	2.95e-05	0.000177	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.78e-05	0.000167	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	2.77e-05	0.000167	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—TPI1—osteoporosis	2.74e-05	0.000165	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—P4HB—osteoporosis	2.58e-05	0.000155	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GAPDH—osteoporosis	2.53e-05	0.000152	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—RAP1A—osteoporosis	2.46e-05	0.000148	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ENO1—osteoporosis	1.99e-05	0.00012	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PSMA5—osteoporosis	1.96e-05	0.000118	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PSMA2—osteoporosis	1.96e-05	0.000118	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP19A1—osteoporosis	1.59e-05	9.57e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ADCY5—osteoporosis	1.3e-05	7.82e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GPX1—osteoporosis	1.3e-05	7.8e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—MTHFR—osteoporosis	1.2e-05	7.19e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—POMC—osteoporosis	9.57e-06	5.75e-05	CbGpPWpGaD
